Cargando…

Identification of a 13-gene-based classifier as a potential biomarker to predict the effects of fluorouracil-based chemotherapy in colorectal cancer

The aim of the current study was to develop a predictor classifier for response to fluorouracil-based chemotherapy in patients with advanced colorectal cancer (CRC) using microarray gene expression profiles of primary CRC tissues. Using two expression profiles downloaded from the Gene Expression Omn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gan, Zuhuan, Zou, Qiyuan, Lin, Yan, Xu, Zihai, Huang, Zhong, Chen, Zhichao, Lv, Yufeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507297/ https://www.ncbi.nlm.nih.gov/pubmed/31186717 http://dx.doi.org/10.3892/ol.2019.10159

Ejemplares similares

Identification and Validation of a Malignant Cell Subset Marker-Based Polygenic Risk Score in Stomach Adenocarcinoma Through Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data
por: Zou, Qiyuan, et al.
Publicado: (2021)

Identification of the association between HMMR expression and progression of hepatocellular carcinoma via construction of a co-expression network
por: Lu, Donglan, et al.
Publicado: (2020)

Construction and validation of a seven-microRNA signature as a prognostic tool for lung squamous cell carcinoma
por: Gan, Zuhuan, et al.
Publicado: (2019)

Identification of key genes involved in the metastasis of clear cell renal cell carcinoma
por: Wei, Wenhao, et al.
Publicado: (2019)

Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer
por: Huang, Xingxing, et al.
Publicado: (2022)

Identification of Hub Genes Associated With Sensitivity of 5-Fluorouracil Based Chemotherapy for Colorectal Cancer by Integrated Bioinformatics Analysis
por: Wang, Ya, et al.
Publicado: (2021)

Three Biomarkers Predict Gastric Cancer Patients' Susceptibility To Fluorouracil-based Chemotherapy
por: Pan, Jiaomeng, et al.
Publicado: (2019)

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
por: Boulay, J-L, et al.
Publicado: (2002)

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
por: Boulay, J-L, et al.
Publicado: (2003)

CXCL-13 Regulates Resistance to 5-Fluorouracil in Colorectal Cancer
por: Zhang, Guolin, et al.
Publicado: (2020)

Predicting the effect of 5‐fluorouracil–based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles
por: Chen, Quan, et al.
Publicado: (2020)

Anemoside B4 sensitizes human colorectal cancer to fluorouracil-based chemotherapy through src-mediated cell apoptosis
por: He, Xing, et al.
Publicado: (2021)

GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy
por: Wang, Zaozao, et al.
Publicado: (2014)

Meta-Analysis of 5-Fluorouracil-Based Chemotherapy Combined With Traditional Chinese Medicines for Colorectal Cancer Treatment
por: Chen, Peng, et al.
Publicado: (2019)

Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based Chemotherapy
por: Zhou, Xingqin, et al.
Publicado: (2021)

Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer
por: Chen, Yi-Qing, et al.
Publicado: (2021)

In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer
por: Kwon, Hye Youn, et al.
Publicado: (2016)

A Case of Wernicke's Encephalopathy Following Fluorouracil-based Chemotherapy
por: Cho, In Jeong, et al.
Publicado: (2009)

A Case of Neurotoxicity Following 5-Fluorouracil-based Chemotherapy
por: Ki, Seung Seog, et al.
Publicado: (2002)

Acute hyperammonemic encephalopathy after 5-fluorouracil based chemotherapy
por: Yi, Hee Jung, et al.
Publicado: (2016)

DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
por: Wigle, Theodore J., et al.
Publicado: (2019)

Thymidine phosphorylase expression and prognosis in colorectal cancer treated with 5-fluorouracil-based chemotherapy: A meta-analysis
por: Che, Jia, et al.
Publicado: (2017)

Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy
por: Tong, M, et al.
Publicado: (2016)

Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids
por: Sabeti Aghabozorgi, Amirsaeed, et al.
Publicado: (2020)

Optimal Duration of Fluorouracil-Based Adjuvant Chemotherapy for Patients with Resectable Gastric Cancer
por: Qu, Jing-lei, et al.
Publicado: (2013)

Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts
por: Na, Deukchae, et al.
Publicado: (2021)

Impact of 5-fluorouracil metabolizing enzymes on chemotherapy in patients with resectable colorectal cancer
por: OCHIAI, TAKUMI, et al.
Publicado: (2014)

Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
por: Graziano, F, et al.
Publicado: (2008)

Association between poorly differentiated clusters and efficacy of 5-fluorouracil-based adjuvant chemotherapy in stage III colorectal cancer
por: Tajima, Yosuke, et al.
Publicado: (2017)

Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy
por: Tsavaris, Nicolas, et al.
Publicado: (2008)

MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms
por: Amankwatia, E B, et al.
Publicado: (2015)

Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy
por: Tsavaris, Nicolas, et al.
Publicado: (2009)

Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer: A Quality-Adjusted Meta-Analysis of Randomized Controlled Trials
por: McCulloch, Michael, et al.
Publicado: (2016)

Systematic review and meta-analysis of tumour microsatellite-instability status as a predictor of response to fluorouracil-based adjuvant chemotherapy in colorectal cancer
por: Aggarwal, Nikhil, et al.
Publicado: (2021)

Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer
por: Holma, Reetta, et al.
Publicado: (2020)

Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer
por: Wang, Di, et al.
Publicado: (2022)

Identification of Predictive DNA Methylation Biomarkers for Chemotherapy Response in Colorectal Cancer
por: Baharudin, Rashidah, et al.
Publicado: (2017)

Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy
por: Godai, Ten-i, et al.
Publicado: (2009)

Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs
por: OCHIAI, TAKUMI, et al.
Publicado: (2013)

Thymidylate synthase expression in primary colorectal cancer as a predictive marker for the response to 5-fluorouracil- and oxaliplatin-based preoperative chemotherapy for liver metastases
por: Takeyama, Hiroshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qukr36pp24im8tmi3ggkekdkm5